Skip to Content
Morningstar

Goldman Sachs Intl Eq Insghts C GCICX

Morningstar Medalist Rating
Medalist Rating as of | See Goldman Sachs Investment Hub
  • NAV / 1-Day Return 12.29  /  0.57 %
  • Total Assets 1.6 Bil
  • Adj. Expense Ratio
    1.930%
  • Expense Ratio 1.930%
  • Distribution Fee Level Average
  • Share Class Type Level Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 2.43%
  • Turnover 151%

USD | NAV as of Sep 29, 2023 | 1-Day Return as of Sep 29, 2023, 11:38 PM GMT+0

Morningstar’s Analysis GCICX

Will GCICX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Process Pillar

The Process Pillar is our assessment of how sensible, clearly defined, and repeatable GCICX’s performance objective and investment process is for both security selection and portfolio construction.

People Pillar

The People Pillar is our evaluation of the GCICX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

Parent Pillar

The Parent Pillar is our rating of GCICX’s parent organization’s priorities and whether they’re in line with investors’ interests.

A worthwhile quantitative offering at the right price.

Analyst Paul Ruppe

Paul Ruppe

Analyst

Summary

Goldman Sachs International Equity Insights remains in capable hands following a late-2022 manager departure. Its well-resourced investment team and decent quantitative approach earn the strategy’s share classes Morningstar Analyst Ratings of Bronze or Neutral, depending on fees.

by Paul Ruppe
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GCICX

More GCICX Holdings
  • Current Portfolio Date
  • Equity Holdings 282
  • Bond Holdings 0
  • Other Holdings 20
  • % Assets in Top 10 Holdings 13.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

ASML Holding NV

1.91
31,959,209
Technology

Novo Nordisk A/S Class B

1.64
27,478,188
Healthcare

British American Tobacco PLC

1.47
24,624,550
Consumer Defensive

Stellantis NV

1.43
23,866,036
Consumer Cyclical

Novartis AG Registered Shares

1.35
22,566,020
Healthcare

SAP SE

1.28
21,361,794
Technology

Roche Holding AG

1.26
20,975,292
Healthcare

Mitsubishi HC Capital Inc

1.20
19,971,806
Financial Services

Bayerische Motoren Werke AG

1.15
19,261,754
Consumer Cyclical

ORIX Corp

1.12
18,699,834
Financial Services